MEDI-3617 - AstraZeneca
AstraZeneca: Q4 & FY 2014 Results (AstraZeneca) - Feb 7, 2015 - Anticipated completion of P1 trial for solid tumours and ovarian cancer in Q3 2016 
Anticipated trial completion date • Oncology • Ovarian Cancer
http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DClinical-trials-appendix.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285686760440&ssbinary=true
 
Feb 7, 2015
 
.